MAPT and Alzheimer disease: Total and phosphorylated MeCP2 levels were increased in human AD brain tissue and in the hippocampus of transgenic mouse overexpressing the human tau gene (Maphis et al., 2017), suggesting that MeCP2 may regulate tau pathology.